Publication | Open Access
Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial
73
Citations
37
References
2019
Year
ClinicalTrials.gov NCT01377246; EudraCT: 2011-000138-12.
| Year | Citations | |
|---|---|---|
Page 1
Page 1